Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2002 1
2006 1
2007 1
2013 1
2016 2
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Factor 5 and Factor VIII, combined deficiency of, 2"
Page 1
Treatment of rare factor deficiencies in 2016.
Peyvandi F, Menegatti M. Peyvandi F, et al. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):663-669. doi: 10.1182/asheducation-2016.1.663. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913544 Free PMC article. Review.
Rare bleeding disorders (RBDs) are a heterogeneous group of coagulation disorders characterized by fibrinogen, prothrombin, factors V, VII, X, XI, or XIII (FV, FVII, FX, FXI, or FXIII, respectively), and the combined factor V + VIII and vitamin K-depen …
Rare bleeding disorders (RBDs) are a heterogeneous group of coagulation disorders characterized by fibrinogen, prothrombin, factors V, VII, …
Combined factor V and VIII deficiency and pregnancy--need for an early protocol-based multidisciplinary management.
Hoffmann C, Falzone E, Mihai A, Gitz L, Itzhar-Baikian N, Martel-Jacob S, Mercier FJ. Hoffmann C, et al. Ann Fr Anesth Reanim. 2013 Nov;32(11):e163-5. doi: 10.1016/j.annfar.2013.08.014. Epub 2013 Oct 23. Ann Fr Anesth Reanim. 2013. PMID: 24161289
We report the medical management of a 32-year-old primigravida, after she was found to have a combined factor V (FV) and factor VIII (FVIII) deficiency during pregnancy. A routine coagulation profile performed during the 6th month of preg …
We report the medical management of a 32-year-old primigravida, after she was found to have a combined factor V (FV) an …
Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study.
Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Dobry AS, et al. JAMA Dermatol. 2018 Feb 1;154(2):182-187. doi: 10.1001/jamadermatol.2017.4920. JAMA Dermatol. 2018. PMID: 29238798 Free PMC article.
MAIN OUTCOMES AND MEASURES: The rate of various hypercoagulable states (ie, antithrombin III [ATIII] deficiency, protein C and S deficiency, factor V Leiden mutation, prothrombin gene mutation [G20210A], elevated factor VIII level, lupus …
MAIN OUTCOMES AND MEASURES: The rate of various hypercoagulable states (ie, antithrombin III [ATIII] deficiency, protein C and S d …
Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
Mansouritorghabeh H, Shirdel A. Mansouritorghabeh H, et al. J Thromb Haemost. 2016 Feb;14(2):336-9. doi: 10.1111/jth.13207. Epub 2016 Jan 30. J Thromb Haemost. 2016. PMID: 26599105 Free article.
ESSENTIALS: Combined factor V (FV) and factor VIII (FVIII) deficiency (CF5F8D) is an autosomal recessive coagulation disorder. ...DDAVP can be substituted for FVIII concentrates in patients with CF5F8D. OBJECTIVES: Combined fact …
ESSENTIALS: Combined factor V (FV) and factor VIII (FVIII) deficiency (CF5F8D) is an autosomal rec …
Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
Murray D, Pennell B, Olson J. Murray D, et al. Transfusion. 1999 Jan;39(1):56-62. doi: 10.1046/j.1537-2995.1999.39199116895.x. Transfusion. 1999. PMID: 9920167 Clinical Trial.
BACKGROUND: Prothrombin time (PT) and activated partial thromboplastin time (APTT) are used to diagnose causes of increased surgical bleeding and to guide treatment of acquired coagulation factor deficiency. This study compared the sensitivity of various commercial …
BACKGROUND: Prothrombin time (PT) and activated partial thromboplastin time (APTT) are used to diagnose causes of increased surgical bleedin …
Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cells.
Martino M, Luise F, Oriana V, Console G, Moscato T, Mammì C, Messina G, Massara E, Irrera G, Piromalli A, Lombardo VT, Laganà C, Iacopino P. Martino M, et al. Tumori. 2007 Mar-Apr;93(2):155-9. doi: 10.1177/030089160709300208. Tumori. 2007. PMID: 17557562 Clinical Trial.
Thrombophilia screening comprised of testing for factor V Leiden G1691A, prothrombin G20210A, the thermolabile variant (C677T) of the methylene tetrahydrofolate reductase gene, protein C, protein S, factor VIII and homocysteine plasmatic levels, antith …
Thrombophilia screening comprised of testing for factor V Leiden G1691A, prothrombin G20210A, the thermolabile variant (C677T) …
Circumcision in a combined factor V and factor VIII deficiency using desmopressin (DDAVP).
Devecioğlu O, Eryilmaz E, Celik D, Unüvar A, Karakaş Z, Anak S, Ağaoğlu L. Devecioğlu O, et al. Turk J Pediatr. 2002 Apr-Jun;44(2):146-7. Turk J Pediatr. 2002. PMID: 12026204
Combined factor V and VIII deficiency is a rare inherited autosomal recessive single gene disorder commonly seen in the Middle East. ...We report an eight-year-old boy with factor V and VIII deficiency who underwent a …
Combined factor V and VIII deficiency is a rare inherited autosomal recessive single gene disorder common …
Screening for identified and unidentified protein C pathway defects by the Agkistrodon contortrix venom test in consecutive patients.
Robert A, Aillaud MF, Eschwège V, Verdy E, Barthet MC, Morange PE, Juhan-Vague I. Robert A, et al. Am J Clin Pathol. 1999 Aug;112(2):233-7. doi: 10.1093/ajcp/112.2.233. Am J Clin Pathol. 1999. PMID: 10439804 Clinical Trial.
To determine the real performance of the Agkistrodon contortrix venom (ACV) screening test for protein C (PC) pathway defects, we studied 400 consecutive patients referred for the study of personal venous thrombosis or for family study. All 82 patients with factor V …
To determine the real performance of the Agkistrodon contortrix venom (ACV) screening test for protein C (PC) pathway defects, we studied 40 …
A fatal case of enoxaparin induced skin necrosis and thrombophilia.
Nadir Y, Mazor Y, Reuven B, Sarig G, Brenner B, Krivoy N. Nadir Y, et al. Eur J Haematol. 2006 Aug;77(2):166-8. doi: 10.1111/j.1600-0609.2006.00668.x. Eur J Haematol. 2006. PMID: 16856910
Other causes of skin necrosis, including heparin induced thrombocytopenia, disseminated intravascular coagulation, protein C/protein S deficiencies, anti-phospholipid antibodies, and vitamin K deficiency were less likely in this case. The concomitant combined …
Other causes of skin necrosis, including heparin induced thrombocytopenia, disseminated intravascular coagulation, protein C/protein S de …